Author(s): Radosevi K, Rodriguez A, Lemckert A, Goudsmit J, Radosevi K, Rodriguez A, Lemckert A, Goudsmit J
Abstract Share this page
Abstract Classical vaccination approaches, based on a single vaccine administered in a homologous prime-boost schedule and optimized to induce primarily neutralizing antibodies, are unlikely to be sufficiently efficacious to prevent TB, malaria or HIV infections. Novel vaccines, capable of inducing a more powerful immune response, in particular T-cell immunity, are desperately needed. Combining different vaccine modalities that are able to complement each other and induce broad and sustainable immunity is a promising approach. This review provides an overview of heterologous prime-boost vaccination modalities currently in development for the 'big three' poverty-related diseases and emphasizes the need for innovative vaccination approaches.
This article was published in Expert Rev Vaccines
and referenced in Journal of AIDS & Clinical Research